Tear Protein Microbial Regulation
泪液蛋白微生物调节
基本信息
- 批准号:10615707
- 负责人:
- 金额:$ 47.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-30 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:ATP-Binding Cassette TransportersAffinityAffinity ChromatographyAmpicillinAntibodiesBacterial ModelBinding ProteinsBiochemicalBiotinylationBlindnessBostonC-terminalCaenorhabditis elegansCampylobacter jejuniCell DeathCellsCessation of lifeChelating AgentsClinicalCollectionComplementComplementary DNACorneaDevelopmentEncapsulatedEscherichia coliExcisionEyeEye InfectionsFrancisella tularensisGeneticGenetic ScreeningGoalsHelicobacter pyloriHumanIndividualInfectionIronKnock-outLegionella pneumophilaMass Spectrum AnalysisMassachusettsMediatingMediatorMembraneMembrane ProteinsMitogensMutateNamesOutcomeParentsPeptidesPolyaminesPseudomonas aeruginosaPutrescineReflex actionRegulationResistanceRoleSourceSpermidineStaphylococcus aureusStaphylococcus epidermidisSupplementationSurfaceSurface Plasmon ResonanceSystemTestingUlcerUniversitiesUropathogenic E. coliVirginiaVirulenceVirulence FactorsWorkantimicrobialbactericidecell growthcommensal bacteriaextracellularinhibitorknockout genemetabolomicsmicrobialmicrobicidemouse modelmutantnovel therapeuticsnucleaseocular surfaceopportunistic pathogenpathogenperiplasmresistant strainrespiratorysolutesyndecansynthetic peptidetear proteinsuptake
项目摘要
Tear microbicidal activity protects the surface of the eye from environmental pathogens and may regulate levels
of commensal bacteria. Lacritin, a prosecretory mitogen enriched in human basal and reflex tears, is subject to
cleavage-potentiated release of C-terminal proteoforms, including those bactericidal for E. coli, P. aeruginosa
(Migula and PA14), L. monoctyogenes, S. aureus and S. epidermidis. Removal of C-terminal proteoforms from
human tears by repeated passage over anti-lacritin C- (but not N-) terminal antibody columns depletes all tear
antimicrobial activity, an activity encapsulated in the synthetic peptide AQKLLKKFSLLKPWA 'N-104', also a
proteoform. As a cationic, largely a-helical amphipathic peptide, death by membrane disruption would be
expected - a hypothesis largely ruled out by surface plasmon resonance with model bacterial membranes, and
metabolomic analysis with parent 'N-65' fragment that suggests a regulated cell death mechanism. Very
revealing were screens for N-104 resistant mutants out of the full E. coli Keio collection of 3,985 nonessential
gene knockouts. Knockout of feoB, potH, ybaE, yhfZ or ybdM was sufficient to confer resistance, but not to
equimolar amounts of ampicillin. The same is true for feoB and potH transposon insertion mutants of
opportunistic pathogen P. aeruginosa PA14. YbaE and YbdM are uncharacterized in E. coli and P. aeruginosa
where functions may differ. YhfZ is absent from P. aeruginosa. FeoB is a well-known virulence factor of
respiratory P. aeruginosa, F. tularensis and L. pneumophila, gut C. jejuni and H. pylori, and uropathogenic E.
coli, but has not previously been associated with ocular infections. FeoB and PotH contribute to or form
respective ferrous iron and putrescine and uptake channels, YbaE (with proposed name 'bacterial extracellular
solute-binding protein') appears to be an ABC transporter subunit with a genetic interaction to outer membrane
protein A, and YbdM is a ParB domain containing nuclease. Ferrous iron and putrescine are each essential for
bacterial cell growth, and yet are also required by host cells, especially the avascular cornea. Media
supplementation with a 10-fold molar excess of putrescine, but not fellow polyamine spermidine, completely
abrogates N-104 dependent bacterial death (tear putrescine is 1/10th that of N-104 proteoform).
Complementation of potH- E. coli by potH+ cDNA does the opposite. Prior metabolomic studies (that did not
detect ferrous iron) revealed that N-104 parent 'N-65' rapidly suppresses intracellular E. coli putrescine. Our
immediate focus is on FeoB and PotH. Our working hypothesis is that FeoB and/or PotH are virulence
mechanisms for ocular surface pathogens with N-104 a main source of tear bactericidal activity. Our immediate
goal is to elucidate how N-104, through FeoB or PotH triggers killing.
University of Virginia Charlottesville Virginia
Harvard University Boston Massachusetts
撕裂杀生活性可保护眼表面免受环境病原体的侵害,并可能调节水平
共生细菌。富集在人类基底和反射泪中的起诉促促促促促促丝线元素
C末端蛋白基型的切割式释放释放,包括大肠杆菌的杀菌性,铜绿假单胞菌
(Migula和Pa14),L。单胞菌,金黄色葡萄球菌和表皮链球菌。从中去除C末端蛋白基
通过反复通过抗透眼蛋白C-(但不是n-)末端抗体柱耗尽的人眼泪
抗菌活性,一种封装在合成肽Aqkllkkfsllkpwa'N-104'中的活性,也是
蛋白质成型。作为一种阳离子,很大程度上是一个螺旋的两亲性肽,膜破坏的死亡将是
预期 - 一个假设在很大程度上被表面等离子体与模型细菌膜共鸣的假设,并且
代谢组学分析的“ N-65”片段表明受调节的细胞死亡机制。非常
揭示是从3,985个非必需的全大肠杆菌收藏中的N-104抗性突变体的筛选
基因淘汰。 FEOB,POTH,YBAE,YHFZ或YBDM的淘汰赛足以赋予抵抗力,但不适合
等摩尔量的氨苄青霉素。对于FeOB和Poth Transposon插入突变体也是如此
机会性病原体P.铜绿PA14。 YBAE和YBDM在大肠杆菌和铜绿假单胞菌中未表征
功能可能有所不同。铜绿假单胞菌没有YHFZ。 FEOB是众所周知的毒力因子
呼吸道P.铜绿假单胞菌,F。tularensis和L.肺炎,肠道C. jejuni和H. Pylori以及尿道病E.
大肠杆菌,但以前尚未与眼部感染有关。 Feob和Poth贡献或形成
Ybae(带有细菌细胞外的名称'
溶质结合蛋白')似乎是ABC转运蛋白亚基,具有与外膜的遗传相互作用
蛋白A和YBDM是含有核酸酶的PARB结构域。亚铁和腐烂都是必不可少的
细菌细胞生长,但也需要宿主细胞,尤其是血管角膜。媒体
补充10倍过量的腐烂,但不添加多胺精子,完全是
废除N-104依赖性细菌死亡(撕裂腐烂是N-104蛋白质成型的1/10)。
Poth+ cDNA对Poth-E. cosi的互补并恰恰相反。先前的代谢组学研究(没有
检测铁铁)表明N-104母体“ N-65”迅速抑制了细胞内大肠杆菌腐烂。我们的
直接的重点是Feob和Poth。我们的工作假设是FEOB和/或POTH是毒力
N-104的眼表病原体机制是泪液活性的主要来源。我们的直接
目标是通过FEOB或POTH触发杀戮阐明N-104。
弗吉尼亚大学夏洛茨维尔弗吉尼亚大学
哈佛大学马萨诸塞州波士顿
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gordon William Laurie其他文献
Gordon William Laurie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gordon William Laurie', 18)}}的其他基金
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Production of human mitochondrial ABC transporters for structural and biochemical studies
生产用于结构和生化研究的人类线粒体 ABC 转运蛋白
- 批准号:
10482375 - 财政年份:2021
- 资助金额:
$ 47.22万 - 项目类别:
Production of human mitochondrial ABC transporters for structural and biochemical studies
生产用于结构和生化研究的人类线粒体 ABC 转运蛋白
- 批准号:
10354245 - 财政年份:2021
- 资助金额:
$ 47.22万 - 项目类别:
Activation of immune receptor signaling by a sulfated peptide
硫酸化肽激活免疫受体信号传导
- 批准号:
9912789 - 财政年份:2017
- 资助金额:
$ 47.22万 - 项目类别: